Why the study?
Do ACE inhibitors potentiate endothelium-dependent vasodilation of coronary arteries in the presence of bradykinin?
Do ACE inhibitors potentiate endothelium-dependent vasodilation of coronary arteries in the presence of bradykinin?
ACE inhibitors potentiate endothelium-dependent vasodilation to bradykinin in coronary arteries via a local mechanism, independent of systemic kinin accumulation.
No takes yet. Share an insight, caveat, or question.
Highlights potential local coronary effects of ACE inhibitors; leaves open translation to human disease.
Auch–Schwelk et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: